Context: Vitamin D deficiency contributes to skeletal diseases and is highly prevalent among institutionalized elderly patients. Whether low 25-hydroxyvitamin D (25[OH]D) concentrations are an independent risk factor for mortality in these patients is, however, unclear.
V
itamin D deficiency is considered a causal risk factor for skeletal diseases, which justifies recommendations for dietary vitamin D intakes (1, 2) . Particular attention is paid to institutionalized elderly patients because prevalence of vitamin D deficiency is extraordinarily high among these individuals (2, 3) . This in turn led to recommendations for vitamin D intake doses in the elderly (mostly 800 IU/d) that are higher than for any other age group (1, 4, 5) . In this context, it should also be noted that a previous meta-analysis suggests that vitamin D supplementation may decrease total mortality in older individuals, but this has not been specifically addressed in elderly institutionalized patients (6) . Meta-analyses of observational studies showed an inverse relationship between vitamin D status and mortality (7, 8) . It has been documented that low 25-hydroxyvitamin D (25[OH]D) concentrations are associated with increased risk of mortality in the general population as well as in patients with chronic kidney disease (7, 8) . By contrast, the situation is less clear for institutionalized elderly patients because only one previous study addressed this topic in such individuals (9) . In that study, Sambrook et al. (9) examined 842 older people (mean age 81.9 yr; 78.4% females) residing in hostels and nursing homes in Northern Sydney. Higher 25(OH)D was associated with decreased mortality in ageand gender-adjusted analyses, but there was no significant relationship after multivariate adjustments (9) . Therefore, the independent association of 25(OH)D with mortality remains to be further studied. We addressed this in a large prospective cohort of female nursing home residents in Austria (10, 11) .
Subjects and Methods

Study population
Our study population consists of older (Ͼ70 yr) female patients of Caucasian origin who were recruited from 95 nursing homes in Austria. Baseline characteristics and study procedures have been extensively described in two previously published reports (10, 11) . In brief, eligible study participants had to be able to walk a short distance independently. Main exclusion criteria were malignancies, hypercalcemia, advanced kidney or liver dysfunction, bilateral hip replacements, history of total gastrectomy, decompensated heart failure, chronic alcoholism, known osteomalacia, untreated thyroid disease, or chronic steroid treatment (10, 11) . Mobility scoring was performed as previously published (10, 11) : score 1, walking independently and outside the institution; score 2, walking inside nursing home, majority using a walking aid but not a wheelchair; score 3, staying in bed less than 50% during daytime, majority requiring a wheelchair; score 4, staying in bed more than 50% during daytime. We measured quadriceps knee extensor strength in kiloponds. This was done on the nondominant side by using a validated, hand-held isometric device (model DPPH; Industrial Scale Inc., Houston, TX). All study participants were followed up with respect to mortality. Written informed consent was obtained from all study participants, and the study protocol was approved by the local ethics committees.
Laboratory methods
Laboratory procedures have been previously described in detail, and all laboratory parameters were simultaneously measured at a single central laboratory (10, 11) . Nonfasting blood samples were collected between 0900 and 1200 h and were immediately stored at Ϫ70 C until analysis. 25(OH)D was measured in serum by RIA after extraction (Immunodiagnostic Systems, Boldon, UK). According to manufacturerЈs instructions, the intraassay coefficients of variation were 5.3 and 5.0% at mean 25(OH)D concentrations of 26.5 and 58.4 nmol/liter, respectively. Interassay coefficients of variation were 8.2 and 8.1% at mean 25(OH)D concentrations of 19.6 and 56.7 nmol/liter, respectively. The detection limit of our 25(OH)D assay is 3 nmol/liter. Other assay methods have been described elsewhere (10, 11) .
Statistical analyses
According to their distribution, continuous data are either presented as means Ϯ SD or as medians with interquartile range. Categorical data are presented as percentages. Differences across groups are tested by ANOVA for continuous variables and by 2 test or Fisher's exact test for categorical data. We calculated Cox proportional hazard ratios (HR) for mortality according to 25(OH)D quartiles with the fourth quartile as the reference. We present crude HR as well as HR adjusted for age (years) (model 1). Additional adjustments are done for the possible confounders body mass index (BMI) (kilograms per square meter) and albumin (grams per deciliter) in model 2, and for creatinine clearance (milliliters per minute, calculated according to Cockcroft-Gault), glycated hemoglobin (percent), arterial hypertension (yes/no), and coronary artery disease (yes/no) in model 3. Additional adjustments were performed for parameters of mineral metabolism including serum calcium (millimoles per liter), serum phosphate (milligrams per deciliter), and PTH in model 4. Finally, we additionally adjust for mobility score (1-4) and quadriceps knee extensor strength (kiloponds) in model 5. A P value Ͻ0.05 was considered statistically significant. SPSS version 17.0 (SPSS Inc., Chicago, IL) was used for statistical analyses.
Results
From the initial cohort of 1664 study participants, 961 agreed to undergo a blood draw with subsequent measurements of 25(OH)D and were thus included into the present work. There were no significant differences in clinical characteristics (i.e. age, BMI, or mobility status) between those study participants with and without blood samplings. Blood samplings for 25(OH)D were exclusively performed in February and March 2002. Mean age was 83.7 Ϯ 6.1 yr, and median 25(OH)D concentrations were 17.5 (13.7-25.5) nmol/liter (divide by 2.496 to convert nanomoles per liter to nanograms per milliliter). Only 69 patients (7.2% of the study population) had 25(OH)D levels of 50 nmol/liter or higher. Baseline characteristics of the study population according to 25(OH)D quartiles are presented in Table 1 .
We recorded 284 deaths (30% of the study cohort) after a mean follow-up time of 27 Ϯ 8 months (range 2-34 months). Cox proportional HR for mortality according to 25(OH)D quartiles are presented in Table 2 . Age-adjusted HR (with 95% confidence interval) for mortality was 1.49 (1.07-2.10) in the first compared with the fourth 25(OH)D quartile, and this association remained significant even after multivariable adjustments (see Table 2 ).
Discussion
In a large cohort of institutionalized elderly women, we have shown that lower 25(OH)D levels are highly prevalent in winter and are associated with increased mortality.
The observation of extremely low 25(OH)D concentrations in our study participants is in line with previous investigations among institutionalized elderly people (2, 3, (12) (13) (14) (15) . Hence, our data suggest that although the high prevalence of vitamin D deficiency among frail elderly people in Europe has already been known for several decades, no efficient strategies have meanwhile been implemented to prevent and treat vitamin D deficiency in these individuals. Limited sunlight access in concert with impaired vitamin D synthesis of the aging skin as well as nutritional deficits may likewise contribute to this high prevalence of vitamin D deficiency. In fact, 25(OH)D concentrations were below the recommended level of 50 nmol/liter in almost all (92.8%) of our study participants. These data have implications for the interpretation of our prospective findings because even our highest group had median 25(OH)D levels well below the cutoff for vitamin D deficiency. Considering a meta-analysis that documented a nonlinear relationship between 25(OH)D and mortality with the lowest mortality risk at 25(OH)D levels ranging from 75-87.5 nmol/liter, it could be hypothesized that availability of an adequate reference group with such (9) . Adjustment for possible confounders, however, attenuated this relationship in that work by Sambrook et al. (9) , which underlines the importance of our work to shed more light into this topic. In this context, it should also be discussed that it is very difficult to differentiate between possible confounders and parameters of the causal chain of vitamin D deficiency because vitamin D may have causal implications for numerous pathophysiological processes (17) (18) (19) (20) . For example, mobility and muscle strength were associated with lower 25(OH)D in our cohort, but these variables could be partially both the cause as well as the consequence of vitamin D deficiency (2, (17) (18) (19) (20) . It may also be acknowledged that due to the previously shown nonlinear associations of 25(OH)D and mortality (8) Our results are limited because we examined elderly female Caucasians recruited from nursing homes in Austria. These findings may therefore not be generalizable to other populations. Given that this was a prospective observational study, we cannot draw conclusions regarding causality. Blood samplings in February and March may have contributed to a particularly poor vitamin D status due to the seasonal lowering of 25(OH)D in winter. However, this relatively narrow time window for blood collections may have also minimized the possible influence of season on our prospective analyses. We also have to acknowledge that data on cause-specific mortality as well as on vitamin D supplementation during follow-up were not available. Despite careful adjustments, we cannot rule out the existence of unconsidered confounders. On the other hand, we might have overadjusted our analyses for parameters of the causal chain.
In conclusion, our Austrian study showed that the majority of elderly institutionalized women were vitamin D deficient in winter. We observed a significantly increased mortality risk in those patients with the lowest 25(OH)D levels. In view of these findings and the existing literature on adverse effects of vitamin D deficiency, there exists now an urgent need for effective strategies to improve vitamin D status in older institutionalized patients.
